FDA’s December 2025 OPOE list features 784 prescription drugs, 73 OTC drugs
This
week, PharmaCompass brings you key highlights of the US Food and Drug Administration’s D
FDA approvals drop 24% in H1 2025; GSK’s UTI med, Vertex’s non-opioid painkiller lead pack of first-in-class meds
It has been a turbulent year for the US
Food and Drug Administration (FDA), marked by reduction

Market Place
Sourcing Support